John Christopher Lindon
Director/Board Member at Metabometrix Ltd.
Profile
John Christopher Lindon is currently a Director at Metabometrix Ltd.
and a Professor at Imperial College London.
Previously, he was a Professor of Biomolecular Medicine at the University of London and Head of Spectroscopy at Wellcome Research Laboratories.
He received his undergraduate degree from the University of Birmingham.
John Christopher Lindon active positions
| Companies | Position | Start |
|---|---|---|
Metabometrix Ltd.
 Metabometrix Ltd. Miscellaneous Commercial ServicesCommercial Services Metabometrix Ltd. provides metabonomics research services. It uses nuclear magnetic resonance technology to generate and interpret high-density metabolic data using robotic flow-injection technology. The firm markets its metabonomic technologies to pharmaceutical and biotechnology companies. Metabometrix was founded by Jeremy Kirk Nicholson in 2000 and is headquartered in London, the United Kingdom. | Director/Board Member | - |
| Imperial College London | Corporate Officer/Principal | - |
Former positions of John Christopher Lindon
| Companies | Position | End |
|---|---|---|
| Wellcome Research Laboratories | Corporate Officer/Principal | 01/01/1995 |
| University of London | Corporate Officer/Principal | - |
Training of John Christopher Lindon
| University of Birmingham | Undergraduate Degree |
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 2 |
|---|---|
Metabometrix Ltd.
Metabometrix Ltd. Miscellaneous Commercial ServicesCommercial Services Metabometrix Ltd. provides metabonomics research services. It uses nuclear magnetic resonance technology to generate and interpret high-density metabolic data using robotic flow-injection technology. The firm markets its metabonomic technologies to pharmaceutical and biotechnology companies. Metabometrix was founded by Jeremy Kirk Nicholson in 2000 and is headquartered in London, the United Kingdom. | Commercial Services |
| Wellcome Research Laboratories |
- Stock Market
- Insiders
- John Christopher Lindon
